December 28, 2014 8:28 PM ET

Biotechnology

Company Overview of Onyx Pharmaceuticals, Inc.

Executive Profile

Antonio J. Grillo-Lopez M. D.

Former Chief Medical Officer and Senior Vice President of Medical & Regulatory Affairs, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 7 different industries.

See Board Relationships
74--

Background

Dr. Antonio J. Grillo-Lopez, M.D. serves as Consultant of clinical research and regulatory strategy to the National Cancer Institute (NCI) and to several biotechnology companies. Dr. Grillo-Lopez served as the Chief Medical Officer Emeritus of IDEC Pharmaceuticals Corporation (now Biogen Idec, Inc.). Previously, he served as Chief Medical Officer and Senior Vice President of medical and regulatory affairs of IDEC Pharmaceuticals Corporation from November 1992 to January ...

Corporate Headquarters

249 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-266-0000
Fax: 650-266-0100

Board Members Memberships

2001-N/A
Former Independent Director and Member of Nominating & Corporate Governance Committee
2001-2009
Former Director
2002-Present
Director and Member of Nominating & Corporate Governance Committee
2002-N/A
Former Director
2007-N/A
Former Director

Education

BS
Universidad de Puerto Rico, San Juan
MD
University of Puerto Rico system

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$985.0K
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
$15.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Onyx Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.